Resources for patients and care teams
Downloadable resources designed to provide the best possible experience with RYTELO.
RYTELO (imetelstat) is a prescription medicine used to treat a condition called low- to intermediate-1 risk myelodysplastic syndromes (MDS) in adults: See more
and
It is not known if RYTELO is safe and effective in children.
Downloadable resources designed to provide the best possible experience with RYTELO.
Downloadable resources designed to provide the best possible experience with RYTELO.
The RYTELO brochure can help you understand LR-MDS with anemia and what to expect while taking RYTELO.
Download the care team conversation guide to help you get the most out of your discussions throughout treatment with RYTELO.
The REACH4RYTELO Patient Support Program helps patients understand insurance coverage and access treatment. To enroll, this form must be completed by both the patient and their care team.
The Copay Program may provide financial support to eligible patients with commercial insurance. This brochure can help you learn more about the support that may be available.
My family has been very helpful, especially my daughter and my wife.”
Real patient with his care partner.
The organizations listed below provide trusted education about myelodysplastic syndromes (MDS), including information on diagnosis, treatment options, and ongoing care. They also offer a wide range of resources, support services, and guidance for people living with MDS and for their families and care partners. They have not endorsed Geron Corporation or any of its respective products or services.
These organizations are independent groups and are shared here for informational purposes only. Inclusion does not imply endorsement of any organization or its content.
These organizations circulate information and bring together providers supporting patients who have MDS. These organizations are independent groups and are shared here for informational purposes only. Inclusion does not imply endorsement of any organization or its content.